| |
| | TAGS GOES HERE --> The Diabetes Control and Complications Trial (DCCT)</u> <i>(Site not responding. Last check: 2007-10-24)</i></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>DCCT</b> was designed to definitively answer whether a program of intensive therapy aimed at near normal levels of glycemia, when compared to conventional therapy aimed at maintenance of clinical well being, would affect the risk of onset and progression of these <b>complications</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Hypoglycemia in the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The absence of a glycemic threshold for the development of long-term <b>complication</b>: the perspective of the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b>.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.bsc.gwu.edu /bsc/studies/dcct.html</font> (978 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.healthatoz.com/healthatoz/Atoz/dc/caz/diab/dia1/diablood.jsp">Preventing Type 1 Diabetes Complications</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> In addition to <b>controlling</b> their blood glucose levels, people with <b>diabetes</b> must be aware of other measures that can help prevent the cardiovascular and cerebrovascular <b>complications</b> of <b>diabetes</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> <b>Diabetic</b> neuropathy can cause a variety of symptoms including pins and needles sensation and severe pain in the hands and legs, or a loss of pain sensation in the extremities (which can contribute to foot problems). </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (<b>DCCT</b>) Epidemiology of <b>Diabetes</b> Interventions and <b>Complications</b> (EDIC).</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.healthatoz.com /healthatoz/Atoz/dc/caz/diab/dia1/diablood.jsp</font> (1383 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.diabetesselfmanagement.com/article.cfm?aid=1280&sid=6&sk=9AAD">Diabetes Self-Management - Diabetes Control and Complications Trial</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> A landmark study that proved that tight blood glucose <b>control</b> can substantially reduce the risk of developing the devastating medical <b>complications</b> of <b>diabetes</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> In addition, the effect of intensive treatment on <b>diabetic</b> <b>complications</b> was stunning. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Intensive insulin therapy reduced the risk of developing <b>diabetic</b> retinal disease by 76%, <b>diabetic</b> nerve disease by 60%, and <b>diabetic</b> kidney disease by 54%.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.diabetesselfmanagement.com /article.cfm?aid=1280&sid=6&sk=9AAD</font> (448 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://journal.diabetes.org/diabetesspectrum/98v11n1/pg33.htm">The Team Approach to Intensive Diabetes Management</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Responsibilities of <b>diabetes</b> nurse clinicians include but need not be limited to providing <b>diabetes</b> education, assisting in the choice of insulin regimen, adjusting insulin dosages, teaching patients problem-solving skills, helping patients work through self-management problems, and developing educational and motivational strategies to promote patients’ independent self-management. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Similarly, in patients for whom chronic <b>diabetes</b> <b>complications</b> have become the focus of treatment (painful, peripheral neuropathy, for example) medical/pharmaceutical intervention may become the focus, and the principal provider may be the physician or pharmacist. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> She was also referred to a tertiary care <b>diabetes</b> clinic, where she was introduced to a team consisting of a diabetologist, a registered nurse who was a certified <b>diabetes</b> educator, a registered dietitian, and a social worker.</td></tr>
<tr><td></td><td colspan=2><font color=gray>journal.diabetes.org /diabetesspectrum/98v11n1/pg33.htm</font> (3155 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.medicine.uiowa.edu/gcrc/highlights/webhilit/dcct.htm">U of Iowa GCRC study: The Diabetes Control and Complications Trial (DCCT)</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Half the subjects adopted intensive treatment of their <b>diabetes</b> -- taking three or four insulin injections daily and checking their blood sugar four times throughout the day to maintain glucose levels as close to normal as possible -- while the other half continued their conventional care. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The development of retinopathy (eye damage) was the same between the two groups for three years, but by the fourth year the gap widened and continued to widen for the remainder of the study. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> For the intensive therapy group to succeed, one of the lessons from the <b>DCCT</b> was that it required a team effort: patients, physicians, nutritionists, nurses, and psychologists.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.medicine.uiowa.edu /gcrc/highlights/webhilit/dcct.htm</font> (476 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.wordsinarow.com/chapter1.html">The Diabetes Control and Complications Trial</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Their <b>"trial"</b> ended in 1993, and the conclusions they drew were very important to anyone with <b>diabetes</b>, whether they have Type I or Type II <b>diabetes</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> This <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (called the <b>"DCCT"</b>) showed conclusively and very scientifically that aggressively, intensively managing one's blood glucose level to keep it as near to "normal" as possible can prevent the development and slow the progression of the <b>complications</b> of <b>diabetes</b> dramatically. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> This is a good place to remember that it is the extra, unneeded glucose in the blood stream, unconfronted and uncontrolled over the long haul, which apparently causes the <b>complications</b> of <b>diabetes</b> to appear or worsen.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.wordsinarow.com /chapter1.html</font> (669 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.niddk.nih.gov/patient/edic/edic-public.htm">NIDDK : Epidemiology of Diabetes Interventions and Complications Study (EDIC)</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The Epidemiology of <b>Diabetes</b> Interventions and <b>Complications</b> Study (EDIC) is an observational study examining the risk factors associated with the long-term <b>complications</b> of type 1 <b>diabetes</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (DCCT)/Epidemiology of <b>Diabetes</b> Interventions and <b>Complications</b> (EDIC) Study is entering its 21st year. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The primary aim of EDIC is to examine the long-term effects of conventional vs. intensive <b>diabetes</b> treatment received during the <b>DCCT</b> on the subsequent development and progression of microvascular, neuropathic and cardiovascular <b>complications</b>.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.niddk.nih.gov /patient/edic/edic-public.htm</font> (275 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.diabetes.org/type-1-diabetes/tight-control.jsp">Tight Diabetes Control - All About Diabetes - American Diabetes Association</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Tight <b>control</b> can prevent or slow the progress of many <b>complications</b> of <b>diabetes</b>, giving you extra years of healthy, active life. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Tight <b>control</b> is most worthwhile for healthy people who can expect to live at least 10 more years. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Their <b>complications</b> are probably too far along to be helped.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.diabetes.org /type-1-diabetes/tight-control.jsp</font> (1620 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.medforum.nl/idm/early.htm">Early deterioration of retinopathy</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Early worsening of <b>diabetic</b> retinopathy in the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>DCCT</b> did not find that slower improvement of <b>diabetic</b> <b>control</b> prevented the appearance of early worsening, although we are not told about the rate of improvement of <b>diabetic</b> <b>control</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The early deterioration is related to the improvement in <b>diabetic</b> <b>control</b>, and in patients in the conventionally treated group this should not have occurred.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.medforum.nl /idm/early.htm</font> (879 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.icoph.org/ed/dcct.html">Retina: Diabetes Control and Complications Trial (DCCT): Appendix 1 - Guidelines and Standards for Education of an ...</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Hoogwerf BJ, Brouhard BH: Glycemic <b>control</b> and <b>complications</b> of <b>diabetes</b> mellitus: practical implications of the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (<b>DCCT</b>). </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Ahern JA, Kruger DF, Gatcomb PM, Petit WA Jr, Tamborlane WV: The <b>diabetes</b> <b>control</b> and <b>complications</b> <b>trial</b> (<b>DCCT</b>): the <b>trial</b> coordinator perspective. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Klein R. Moss S: A comparison of the study populations in the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> and the Wisconsin Epidemiologic Study of <b>Diabetic</b> Retinopathy.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.icoph.org /ed/dcct.html</font> (2121 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.dlife.com/dLife/do/ShowContent/type1_information/preventing_complications/index.html">Type 1 Diabetes Complications, Type 1 Diabetes - dLife.com dLife TV</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Achieving good <b>control</b> over blood glucose levels with insulin and healthy lifestyle changes is the best way to prevent or slow diabetes-related <b>complications</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (<b>DCCT</b>), a landmark ten year study of the impact of good blood sugar <b>control</b> on <b>complications</b> associated with type 1 <b>diabetes</b>, found that for every 1 percentage point a patient reduces their A1c (i.e., three month blood glucose average), they lower their risk of microvascular <b>complications</b> 37%. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> âThe <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> Research Group: The effect of intensive treatment of <b>diabetes</b> on the development and progression of long-term <b>complications</b> in insulin-dependent <b>diabetes</b> mellitus.â N Engl J Med 329:977â“986, 1993.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.dlife.com /dLife/do/ShowContent/type1_information/preventing_complications/index.html</font> (174 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><u>UPHS News: Intensive Glucose Control Cuts Heart Disease Risk in Type 1 Diabetes</u> <i>(Site not responding. Last check: 2007-10-24)</i></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The Division of Endocrinology, <b>Diabetes</b>, and Metabolism at the University of Pennsylvania School of Medicine, with physicians from the Children’s Hospital of Philadelphia (CHOP), was one of 28 centers across the country that participated in the <b>DCCT</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>DCCT</b> findings--that intensive glucose <b>control</b> greatly lowers the eye, nerve, and kidney damage of type 1 diabetes--prompted a major shift in the way doctors manage their patients with type 1 <b>diabetes</b>. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Most people with type 1 <b>diabetes</b> who were treated with conventional glucose <b>control</b>, as it was defined before the <b>DCCT</b>, develop one or more <b>complications</b>, including damage to the heart and blood vessels, eyes, nerves, and kidneys.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.uphs.upenn.edu /news/News_Releases/dec05/T1gluccntrl.htm</font> (1041 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.healthandage.com/Home/gm=2!gid2=2776">Tight Blood Sugar Control Wards Off Diabetes Complications --- HealthandAge</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Keeping blood sugar levels under tight <b>control</b> will lessen the chances of developing or slow the progression of <b>diabetes</b> <b>complications</b> such as eye, kidney, and nerve damage and heart disease. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (<b>DCCT</b>) included teenagers and adults with type 1 <b>diabetes</b>, who were otherwise in good health. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The investigators conclude that people with <b>diabetes</b> should institute and follow intensive treatment as early as possible to minimize the risk of developing kidney disease.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.healthandage.com /Home/gm=2!gid2=2776</font> (622 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.childrenwithdiabetes.com/d_0n_a00.htm">children with DIABETES - The Diabetes Control and Complications Trial</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (<b>DCCT</b>) was a study conducted by the National Institute of <b>Diabetes</b> and Digestive and Kidney Diseases (NIDDK), which is part of the United States National Institutes of Health. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>DCCT</b> demonstrated that people with Type 1 <b>diabetes</b> could reduce the risk of developing <b>complications</b>, and slow the progression of existing <b>complications</b>, by keeping their blood sugar levels as close to non-diabetic levels as possible. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The Effect of Intensive Treatment of <b>Diabetes</b> on the Development and Progression of Long-Term <b>Complications</b> in Insulin-Dependent <b>Diabetes</b> Mellitus (free full text of the <b>DCCT</b> report)</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.childrenwithdiabetes.com /d_0n_a00.htm</font> (157 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=-1187708874">diabetes control and complications trial - General Practice Notebook</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> Research Group undertook a single-blind randomised <b>trial</b> of standard IDDM treatment versus intensive treatment in young patients with no, or mild, <b>diabetic</b> <b>complications</b> at outset. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The study assessed the incidence or progression of the microvascular <b>complications</b> of IDDM, namely retinopathy, nephropathy and neuropathy. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Intensive <b>diabetes</b> treatment and cardiovascular disease in patients with type 1 <b>diabetes</b>.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.gpnotebook.co.uk /simplepage.cfm?ID=-1187708874</font> (1121 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://care.diabetesjournals.org/cgi/content/abstract/29/2/340">Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion -- Martin et al. 29 ...</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Neuropathy Among the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> Cohort 8 Years After <b>Trial</b> Completion -- Martin et al. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Neuropathy Among the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> Cohort 8 Years After <b>Trial</b> Completion </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> (DCCT)/Epidemiology of <b>Diabetes</b> Intervention and <b>Complications</b> (EDIC) Research Group</td></tr>
<tr><td></td><td colspan=2><font color=gray>care.diabetesjournals.org /cgi/content/abstract/29/2/340</font> (357 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><u>Complications of Diabetes</u> <i>(Site not responding. Last check: 2007-10-24)</i></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Ulcers of the legs and feet occur in people with <b>diabetes</b> due to the combination neuropathy and peripheral vascular disease. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> REMEMBER: The care of <b>diabetes</b> is a team effort involving you, your physician, and the <b>diabetes</b> education staff where you receive your medical care. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Different <b>diabetes</b> care teams may approach some aspects of <b>diabetes</b> care in ways that differ from those in this handbook.</td></tr>
<tr><td></td><td colspan=2><font color=gray>www.umassmed.edu /diabeteshandbook/chap12.htm</font> (1627 words)</td></tr>
</table>
</td>
</tr>
</table><body face="Arial">
<br>
<table cellpadding=0>
<tr>
<td> </td>
<td>
<table >
<tr><td> </td><td colspan=2><a href="http://aaaaq.com/diabetes/DCCT">Diabetes Control and Complications Trial (DCCT)</a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> The <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b> was launched by the National Institute of <b>Diabetes</b>, Digestive and Kidney Diseases (NIDDK) in 1981 when requests for proposals were issued for clinical centers and a central Data Coordinating Center. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> In early 1982 the Biostatistics Center of the George Washington University was awarded the contract to serve as the Coordinating Center with Dr. John M. Lachin as Principal Investigator and Director, and Ms. </td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> Elements of Intensive Management in the <b>Diabetes</b> <b>Control</b> and <b>Complications</b> <b>Trial</b></td></tr>
<tr><td></td><td colspan=2><font color=gray>aaaaq.com /diabetes/DCCT</font> (1241 words)</td></tr>
</table>
</td>
</tr>
</table><script language="JavaScript">
<!--
// This function displays the ad results.
// It must be defined above the script that calls show_ads.js
// to guarantee that it is defined when show_ads.js makes the call-back.
function google_ad_request_done(google_ads) {
// Proceed only if we have ads to display!
if (google_ads.length < 1 )
return;
var s = '';
// For text ads, display each ad in turn.
// In this example, each ad goes in a new row in the table.
if (google_ads[0].type == 'text') {
for(i = 0; i < 1; ++i) {
s = '<body face="Arial"><br><table cellpadding=0><tr><td> </td><td><table ><tr><td> </td><td colspan=2>' +
'<a href="' + google_ads[i].url + '" title="' + google_ads[i].visible_url + '">' + google_ads[i].line1 + '</a> <span style="font-size:10pt">';
if (google_info.feedback_url) {
s += '<a href="' + google_info.feedback_url + '" style="color:#7070F0;text-decoration:none">(Ads by Google)</a>';
} else {
s += '(Ads by Google)';
}
s += '</span></td></tr>' +
'<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td>' + '<a href="' + google_ads[i].url + '" title="' + google_ads[i].visible_url + '" style="text-decoration:none;">' + google_ads[i].line2 + ' ' + google_ads[i].line3 + '</a></td></tr>' +
'<tr><td></td><td colspan=2><font color=gray>' + '<a href="' + google_ads[i].url + '" title="' + google_ads[i].visible_url + '" style="text-decoration:none; color:gray;">' + google_ads[i].visible_url +
'</a></font></td></tr></table></td></tr></table>';
d = document.getElementById('ad' + (i + 1));
d.innerHTML = s;
d.style.display = 'block';
}
s = '';
for(i = 1; i < google_ads.length; i++) {
s += '<div class="r" style="margin-left: 14px"><table cellspacing=0 cellpadding=0><tr>' +
// '<td valign=top><img src="/images/a.gif"/ style="padding-top: 3px; padding-right: 3px"></td>' +
'<td ><a href="' + google_ads[i].url + '" title="' + google_ads[i].visible_url + '">' +
google_ads[i].line1 +
'<div style="text-decoration: none; ">' +
google_ads[i].line2 + ' ' + google_ads[i].line3 + '</div></a>' +
'<font color="gray"><a href="'+ google_ads[i].url + '" title="' + google_ads[i].visible_url + '" style="text-decoration:none; color:gray;">' + google_ads[i].visible_url +
'</a></font>' +
'</td></tr></table></div>'
}
d = document.getElementById('sky1');
d.innerHTML = s;
if(s.length > 0) {
document.getElementById('sky').style.display = 'block';
}
}
/*
<body face="Arial"><br><table cellpadding=0><tr><td> </td><td><table ><tr><td> </td><td colspan=2>
<a href=" ### GOOGLE ADS[i] URL ### "> ### GOOGLE ADS[i] VISIBLE URL ### </a></td></tr>
<tr><td valign=top><img style="margin-top:4px;" src=/images/a.gif></td><td></td><td> ### LINE 2 ### ### LINE 3 ###</td></tr>
<tr><td></td><td colspan=2><font color=gray> ### link ### </font> (sponsored link)</td></tr>
</table></td></tr></table>
*/
/*
// For an image ad, display the image; there will be only one .
if (google_ads[0].type == 'image') {
s += '<tr><td align="center">' +
'<a href="' + google_ads[0].url + '"style="text-decoration: none">' +
'<img src="' + google_ads[0].image_url +
'" height="' + google_ads[0].height +
'" width="' + google_ads[0].width +
'" border="0"></a></td></tr>';
}
// Finish up anything that needs finishing up
s += '</table>';
*/
// document.write(s);
return;
}
-->
</script>
<script language="JavaScript">
<!--
// This script sets the attributes for requesting ads.
google_ad_client = "pub-9457578638026753";
google_max_num_ads = 6;
google_feedback = "on";
google_ad_output = "js";
google_ad_channel = "844964098";
google_kw_type = "broad";
google_kw = "Diabetes control and complications trial";
google_ad_type = "text_image";
google_image_size = "728x90";
google_encoding = "latin1";
-->
</script>
<script language="JavaScript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
<br> <p style="margin-left:30px;font-size:13px;"><b>Try your search on: <a href="http://www.qwika.com/find/Diabetes control and complications trial">Qwika</a> (all wikis)</b></p>
<form action=http://www.factbites.com/search.php><table width="100%" cellspacing=0 cellpadding=0 border=0><tr><td background="/images/f1.gif"><table cellspacing=0 cellpadding=0 border=0 background="/images/b.gif"><tr><td><img src="/images/f2.gif" width=38 height=37 alt=" "/></td><td><table cellspacing=0 cellpadding=0 border=0><tr><td><a href="/"><img src="/images/f3.gif" width=95 height=37 alt="Factbites" border=0 /></a><img src="/images/b.gif" width=15 height=1 alt=" "/></td><td valign=bottom><input type=text size=30 name=kp><img src="/images/b.gif" width=2 height=1 alt=" " /><input type=submit value=" Find » " class=b2></td></tr></table></td></tr><tr><td> </td><td><span class=f>
<a href="http://www.factbites.com/about_us.php">About us</a> |
<a href="http://www.factbites.com/why_use_us.php">Why use us?</a> |
<a href="http://www.factbites.com/reviews.php">Reviews</a> |
<a href="http://www.factbites.com/press.php">Press</a> |
<a href="http://www.factbites.com/contact_us.php">Contact us</a>
<br />Copyright © 2005-2007 www.factbites.com Usage implies agreement with <a href=http://www.factbites.com/terms_and_conditions.php>terms</a>.</span></td></tr></table><img src="/images/b.gif" width=450 height=1 alt=" " /></td></tr></table></form>
</body></html>
| |
